ANIP - ANI Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANIP is currently covered by 3 analysts with an average price target of $119.17. This is a potential upside of $22.35 (66.76%) from yesterday's end of day stock price of $71.46.

ANI Pharmaceuticals's activity chart (see below) currently has 39 price targets and 38 ratings on display. The stock rating distribution of ANIP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.7% with an average time for these price targets to be met of 468.86 days.

Highest price target for ANIP is $124, Lowest price target is $115, average price target is $119.17.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 10-Aug-2026. First documented stock forecast 15-Dec-2014.

Currently out of the existing stock ratings of ANIP, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2023

$119

$47.77 (67.06%)

$124

1 months 1 days ago
(10-Aug-2026)

7/12 (58.33%)

$43.24 (57.07%)

320

Buy Since 12-Mar-2025

$115

$43.77 (61.45%)

$85

11 months 18 days ago
(24-Sep-2025)

1/2 (50%)

$20.01 (21.07%)

153

Buy Since 06-Nov-2019

$121

$49.77 (69.87%)

$93

11 months 25 days ago
(17-Sep-2025)

6/7 (85.71%)

$25.64 (26.89%)

453

Buy Since 07-Sep-2022

$94

$22.77 (31.97%)

$94

1 years 5 months 25 days ago
(17-Mar-2025)

13/13 (100%)

$29.65 (46.08%)

317

Buy Since 03-Nov-2021

$60

$-18.36 (-23.43%)

$52

3 years 1 months 21 days ago
(21-Jul-2023)

3/3 (100%)

$7.81 (14.96%)

445

Show more analysts

Please expand the browser size to see the chart

What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?

On average it took 469 days for the stock forecasts to be reached, with an average price target met ratio of 85.7%.

Which analyst most recently updated their price target on ANIP (ANI Pharmaceuticals)?

Vamil Divan

Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?

Vamil Divan works at GUGGENHEIM and has 62 price targets and 38 ratings on ANIP

Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?

Brandon Folkes with the highest potential upside of $49.77

Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?

Elliot Wilbur with the lowest potential downside of -$29.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?